New and established criteria for remission and disease activity in an observational RA cohort treated with etanercept.

被引：0
作者：
Geborek, Pierre
Gulfe, Anders
Aletaha, Daniel
Kristensen, Lars Erik
Saxne, Tore
机构：
[1] Dept Rheumatol, Lund, Sweden
[2] Med Univ Vienna, Dept Rheumatol, Vienna, Austria
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 2 条
[1]   Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states [J].
Aletaha, D ;
Ward, MM ;
Machold, KP ;
Nell, VPK ;
Stamm, T ;
Smolen, JS .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2625-2636
[2]   Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden [J].
Geborek, P ;
Crnkic, M ;
Petersson, IF ;
Saxne, T .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (09) :793-798
1